Education
About Us
Working with TipRanks
Follow Us
Suven Life Sciences Limited (IN:SUVEN)
:SUVEN
| Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 66.56M | ₹ 116.93M | ₹ 135.39M | ₹ 118.44M | ₹ 134.78M |
| Gross Profit | ₹ -276.33M | ₹ 108.69M | ₹ 129.74M | ₹ 94.12M | ₹ 133.75M |
| Operating Income | ₹ -1.72B | ₹ -1.23B | ₹ -1.32B | ₹ -1.26B | ₹ -832.85M |
| EBITDA | ₹ -1.55B | ₹ -992.78M | ₹ -1.11B | ₹ -1.17B | ₹ -721.87M |
| Net Income | ₹ -1.61B | ₹ -1.05B | ₹ -1.18B | ₹ -1.22B | ₹ -721.51M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 600.05M | ₹ 2.40B | ₹ 2.35B | ₹ 504.36M | ₹ 463.54M |
| Total Assets | ₹ 1.35B | ₹ 2.85B | ₹ 3.89B | ₹ 1.08B | ₹ 1.28B |
| Total Debt | ₹ 0.00 | ₹ 7.10M | ₹ 16.05M | ₹ 32.09M | ₹ 47.64M |
| Net Debt | ₹ -377.26M | ₹ -142.23M | ₹ -354.14M | ₹ -20.65M | ₹ -45.85M |
| Total Liabilities | ₹ 251.97M | ₹ 148.62M | ₹ 135.91M | ₹ 118.89M | ₹ 204.12M |
| Stockholders' Equity | ₹ 1.10B | ₹ 2.70B | ₹ 3.75B | ₹ 961.45M | ₹ 1.08B |
| Cash Flow | |||||
| Free Cash Flow | ₹ -1.86B | ₹ -1.15B | ₹ -1.06B | ₹ -1.47B | ₹ -1.02B |
| Operating Cash Flow | ₹ -1.48B | ₹ -1.15B | ₹ -1.03B | ₹ -1.28B | ₹ -960.24M |
| Investing Cash Flow | ₹ 1.49B | ₹ 944.36M | ₹ -2.61B | ₹ -222.29M | ₹ 558.40M |
| Financing Cash Flow | ₹ -7.10M | ₹ -10.54M | ₹ 3.96B | ₹ 1.46B | ₹ 348.56M |